日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Galactose-modified erythrocyte membrane fusion liposomes enable the targeted delivery of drug nanoparticles to the liver.

半乳糖修饰的红细胞膜融合脂质体能够将药物纳米颗粒靶向递送至肝脏

Song Jiayu, Zhang Huanhuan, Zhang Xiaohui, Liu Meiying, Peng Dan, Ren Yuan, Sun Yan, Li Yunlan

Potential Targets and Bioactive Constituents of Daying Decoction in Schizophrenia with Neuroinflammation: A Preliminary Exploratory Integrative Study.

大营汤治疗伴有神经炎症的精神分裂症的潜在靶点和生物活性成分:一项初步探索性综合研究。

Guo Lina, Zhang Bilin, Liu Meiying, Qin Yuxi, Lu Hongxiao, Wang Ze, Yuan Yiting, Zheng Qian, Zhao Guang, Qiao Yanan, Ma Ruodi, Lu Bocheng, Li Yunlan

Network pharmacology, molecular docking, and experimental verification reveal the mechanism of San-Huang decoction in treating acute kidney injury

网络药理学、分子对接及实验验证揭示三黄汤治疗急性肾损伤的作用机制

Jiahui Liu, Zhongtang Li, Yunlan Lao, Xiaoming Jin, Yuzhi Wang, Beibei Jiang, Riming He, Shudong Yang

A broad-host-range lytic phage vB_VhaS-R18L as a candidate against vibriosis

宿主范围广的溶菌噬菌体 vB_VhaS-R18L 可作为抗弧菌病的候选噬菌体

Lanlan Cai, Yuan Tian, Ziqiang Li, Yunlan Yang, Chunxiang Ai, Rui Zhang

Highly Accessible Computational Prediction and In Vivo/In Vitro Experimental Validation: Novel Synthetic Phenyl Ketone Derivatives as Promising Agents against NAFLD via Modulating Oxidoreductase Activity

高度可访问的计算预测和体内/体外实验验证:新型合成苯酮衍生物通过调节氧化还原酶活性作为治疗 NAFLD 的有希望的药物

Yanan Qiao, Huifang Deng, Lihua Liu, Shuran Liu, Luyao Ren, Chuandao Shi, Xi Chen, Lixia Guan, Weiran Liu, Zehua Li, Yunlan Li